The tobacco industry giant, Altria Group, has witnessed a stretch of dynamic stock performance in recent years. While investors have rejoiced periods of increase, the firm's outlook remain a topic of debate. Factors impacting Altria Group's stock comprise regulatory changes, shifting demographics, and the overall health of the tobacco industry. … Read More

The FDA has issued a warning about the risks of smuggled tirzepatide as the peptide therapeutics market grows rapidly. The market is expected to jump from $38 billion in 2023 to $106 billion by 2033, with an impressive 10.8% compound annual growth rate. Legitimate peptide medications have revolutionized modern medicine, with 102 FDA-approved therap… Read More